New rapid and point of care hepatitis C tests could be global game changers

October 15, 2012
This is the point of care test for hepatitis C virus (HCV) infection. Credit: Dr. Nitika Pant Pai

Timely screening and diagnosis is critical to the success of new treatments and ultimately to the survival of hepatitis C patients. A new study led by the Research Institute of the McGill University Health Centre (RI MUHC) is the first to show that hepatitis C rapid and point of care tests with a quick turnaround time are highly accurate and reliable as conventional first-line laboratory tests. This head-to-head analysis, published in the current issue of the Annals of Internal Medicine, will lead to changes in screening practices and ultimately impact the control of hepatitis C infection worldwide.

"We were able to determine that point-of-care and rapid tests in oral fluids and blood ranged in accuracy from 97 to 99 per cent, which is significant," says senior author, Dr. Nitika Pant Pai, Assistant Professor in the Department of Medicine at McGill University and clinical researcher at the RI MUHC. "With their quick turnaround time and convenience we can now use these tests to screen many patients worldwide."

Although conventional lab testing is in place in developed countries, it is available only to those who visit community clinics and specialized hospitals and have a risk profile, or , that warrant screening. Typically, results are available within a week, but may only be communicated to the patient during their next visit, which may be one to three months later. Delays like this may result in reduced patient follow-up and potentially impact transmission of the virus in the community.

Accurate and reliable point-of-care tests and rapid tests offer an alternative to standard tests. "First generation point-of-care tests are convenient, effective and informative for making," explains Dr. Pant Pai. "These tests usually don't require specialized equipment, they can provide results within 30 minutes, or maximally within one patient visit or one working day, and many do not require electricity," adds Sushmita Shivkumar, lead author of the study and a medical student at McGill University.

More than 170 million people are infected with worldwide due to unsafe blood transfusion, injection drug use and unsafe therapeutic injections. Hepatitis C and HIV co-infections contribute substantially to disease burden in North America, but the affect of the disease is highest in Africa and Asia. "With promising oral drugs for Hepatitis C on the horizon, accurate and reliable point-of-care and rapid tests will allow millions of infected individuals worldwide to be diagnosed and treated," explains the study's co-author Dr. Rosanna Peeling, Professor and Chair of Diagnostics Research at the London School of Hygiene & Tropical Medicine.

"These tests have the potential to be game changers on a global scale, particularly where first line conventional laboratory based testing is not financed by under-resourced health systems," concludes Dr. Pant Pai. "It is now time to optimize their potential by integrating them in routine practice settings."

Explore further: Saliva HIV test passes the grade

More information: Accuracy of rapid and point-of-care screening tests for hepatitis C: A systemic review and meta-analysis, annals.org/article.aspx?articleid=1379774

Related Stories

Saliva HIV test passes the grade

January 24, 2012
A saliva test used to diagnose the human immunodeficiency virus (HIV), is comparable in accuracy to the traditional blood test, according to a new study led by the Research Institute of the McGill University Health Centre ...

How accurate are rapid flu tests? New research could lead to more timely diagnosis

February 27, 2012
A new study conducted by researchers from McGill University, the Research Institute of the McGill University Health Centre (RI MUHC), and Sainte-Justine University Hospital Research Centre, Montreal, has put the accuracy ...

Overcoming barriers to point-of-care testing in low-resource settings

September 4, 2012
In a Policy Forum article in this week's PLOS Medicine Madhukar Pai from McGill University, Canada and colleagues discuss a framework for how point-of-care testing can be applied to infectious diseases in low- and middle-income ...

Recommended for you

Sex diseases in US surge to record high

September 26, 2017
Sexually transmitted diseases surged to a record high in the United States last year, with more than two million cases of chlamydia, gonorrhea and syphilis nationwide, officials said Tuesday.

Potential Zika vaccine protects against pregnancy transmission and testicular damage

September 26, 2017
For the first time, a collaborative team led by The University of Texas Medical Branch at Galveston has shown that a potential Zika vaccine quickly can protect fetuses against infection as well as protect males against testicular ...

Antibiotics warranted for kids with minor staph infections

September 26, 2017
The overuse of antibiotics has left some doctors questioning whether to give such drugs to children diagnosed with uncomplicated staph infections. Such infections often occur on the skin and look like a pus-filled bug bite.

Two Group A Streptococcus genes linked to 'flesh-eating' bacterial infections

September 22, 2017
Group A Streptococcus bacteria cause a variety of illnesses that range from mild nuisances like strep throat to life-threatening conditions including pneumonia, toxic shock syndrome and the flesh-eating disease formally known ...

Ecosystem approach makes urinary tract infection more treatable

September 22, 2017
The biological term 'ecosystem' is not usually associated with urinary tract infections, but this should change according to Wageningen scientists.

Residents: Frontline defenders against antibiotic resistance?

September 22, 2017
Antibiotic resistance continues to grow around the world, with sometimes disastrous results. Some strains of bacteria no longer respond to any currently available antibiotic, making death by infections that were once easily ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.